| 49205-8 |
Bartonella elizabethae Ab.IgM |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Bartonella elizabethae IgM Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49205-8 |
|
|
|
|
Both |
|
|
|
0 |
B elizabethae IgM Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B elizabethae; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; R elizabethae; Random; Rochalimae elizabethae; Rochalimaea elizabethae; SmQn; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49206-6 |
Bartonella elizabethae Ab.IgG |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Bartonella elizabethae IgG Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49206-6 |
|
|
|
|
Both |
|
|
|
0 |
B elizabethae IgG Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B elizabethae; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; R elizabethae; Random; Rochalimae elizabethae; Rochalimaea elizabethae; SmQn; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49207-4 |
Bartonella elizabethae Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Bartonella elizabethae IgM Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49207-4 |
|
|
|
|
Both |
|
|
|
0 |
B elizabethae IgM Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B elizabethae; Dilution factor; Dilution Factor (Titer); ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; R elizabethae; Random; Rochalimae elizabethae; Rochalimaea elizabethae; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49208-2 |
Bartonella elizabethae Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Bartonella elizabethae IgG Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49208-2 |
|
|
|
|
Both |
|
|
|
0 |
B elizabethae IgG Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B elizabethae; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; R elizabethae; Random; Rochalimae elizabethae; Rochalimaea elizabethae; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49209-0 |
Bartonella bacilliformis Ab.IgM |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Bartonella bacilliformis IgM Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49209-0 |
|
|
|
|
Both |
|
|
|
0 |
B bacilliformis IgM Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B bacilliformis; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; SmQn; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 4921-3 |
HLA-DPw1 |
PrThr |
Bld/Tiss |
Pt |
Ord |
|
|
ACTIVE |
HLA-DPw1 [Presence] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4921-3 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-DPw1 Ql |
|
|
|
|
|
Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 49210-8 |
Bartonella bacilliformis Ab.IgG |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Bartonella bacilliformis IgG Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49210-8 |
|
|
|
|
Both |
|
|
|
0 |
B bacilliformis IgG Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B bacilliformis; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; SmQn; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49211-6 |
Bartonella bacilliformis Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Bartonella bacilliformis IgM Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49211-6 |
|
|
|
|
Both |
|
|
|
0 |
B bacilliformis IgM Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B bacilliformis; Dilution factor; Dilution Factor (Titer); ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49212-4 |
Bartonella bacilliformis Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Bartonella bacilliformis IgG Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49212-4 |
|
|
|
|
Both |
|
|
|
0 |
B bacilliformis IgG Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B bacilliformis; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49213-2 |
Anaplasma phagocytophilum Ab.IgG |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Anaplasma phagocytophilum IgG Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49213-2 |
|
|
|
|
Both |
|
|
|
0 |
A phagocytoph IgG Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dilution factor; Dilution Factor (Titer); E equi; E phagocytophila; Ehrlichia equi; Ehrlichia phagocytophila; Fl; Fld; FLU; Fluid; HGE; Human granulocytic ehrlichiosis; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; SmQn; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49214-0 |
Anaplasma phagocytophilum Ab.IgM |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Anaplasma phagocytophilum IgM Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49214-0 |
|
|
|
|
Both |
|
|
|
0 |
A phagocytoph IgM Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dilution factor; Dilution Factor (Titer); E equi; E phagocytophila; Ehrlichia equi; Ehrlichia phagocytophila; Fl; Fld; FLU; Fluid; HGE; Human granulocytic ehrlichiosis; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; SmQn; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49215-7 |
PKHD1 gene targeted mutation analysis |
Prid |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
PKHD1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
49215-7 |
|
Molgen |
|
|
Both |
|
|
|
0 |
PKHD1 gene Mut Anl Bld/T |
|
|
|
N |
|
ARPKD; Blood; FCYT; Fibrocystin gene; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Polycystic Kidney and Hepatic Disease 1 (Autosomal Recessive); Random; TIGM1; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.63 |
2.21 |
|
|
|
|
|
|
|
|
|
|
Based on LOINC Committee review (June 2016), "targeted" was added to the Component to clarify that this test is looking for a specific set of mutations as described in the LOINC User Guide under the Molecular Genetics section. |
0 |
| 49216-5 |
Hexokinase |
CCnt |
RBC |
Pt |
Qn |
|
|
ACTIVE |
Hexokinase [Enzymatic activity/mass] in Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
U/g Hb |
|
|
|
|
|
|
CHEM |
|
49216-5 |
|
|
|
|
Both |
|
|
|
0 |
Hexokinase RBC-cCnt |
|
|
|
N |
|
Catalytic Content; Chemistry; Erythrocytes; HK; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles |
2.73 |
2.21 |
|
|
|
|
|
|
|
U/g{Hb} |
|
|
|
0 |
| 49217-3 |
2,3-Diphosphoglycerate |
SCnt |
RBC |
Pt |
Qn |
|
|
ACTIVE |
2,3-Diphosphoglycerate [Moles/mass] in Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
mmol/g hb |
|
|
|
|
|
|
CHEM |
|
49217-3 |
|
|
|
|
Both |
|
|
|
0 |
2,3DPG RBC-sCnt |
|
|
|
N |
|
2,3DPG; 2,3-DPG; Biphosphoglycerate; Chemistry; DPG; Erythrocytes; II; III; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Substance content |
2.4 |
2.21 |
|
|
|
|
|
|
|
mmol/g{Hb} |
|
|
|
0 |
| 49218-1 |
Phosphatidylinositol/Surfactant.total |
MFr |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Phosphatidylinositol/Surfactant.total in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
49218-1 |
|
|
|
|
Both |
|
|
|
0 |
PI MFr Amn |
|
|
|
N |
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; aPI; Chemistry; Mass Fraction; Percent; Phosphatidyl Inositol; PI; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl |
2.3 |
2.21 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 49219-9 |
Galactose |
MCnc |
RBC |
Pt |
Qn |
|
|
ACTIVE |
Galactose [Mass/volume] in Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
49219-9 |
|
|
|
|
Both |
|
|
|
0 |
Galactose RBC-mCnc |
|
|
|
N |
|
Cerebrose; Chemistry; Erythrocytes; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles |
2.34 |
2.21 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
| 4922-1 |
HLA-DPw2 |
PrThr |
Bld/Tiss^Donor |
Pt |
Ord |
|
|
ACTIVE |
HLA-DPw2 [Presence] in Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4922-1 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-DPw2 Donr Ql |
|
|
|
|
|
Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld^donor' to 'Bld/Tiss^donor' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 49220-7 |
Prolactin |
MCnc |
Ser/Plas |
Pt |
Qn |
3rd IS |
|
DISCOURAGED |
Prolactin [Mass/volume] in Serum or Plasma by 3rd IS |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHEM |
|
49220-7 |
|
3rd IS |
|
|
Both |
|
|
|
0 |
Prolactin SerPl 3rd IS-mCnc |
|
|
|
N |
|
3IS; 3rd International Standard; 3rdIS; Chemistry; Lactotropic hormone; Lactotropin; Level; Mammatropic hormone; Mammotropin; Mass concentration; Pl; Plasma; Plsm; Point in time; PRL; Prol; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.21 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 49221-5 |
Catalase |
CCnt |
RBC |
Pt |
Qn |
|
|
ACTIVE |
Catalase [Enzymatic activity/mass] in Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
U/g Hb |
|
|
|
|
|
|
CHEM |
|
49221-5 |
|
|
|
|
Both |
|
|
|
0 |
Catalase RBC-cCnt |
|
|
|
N |
|
Catalytic Content; Chemistry; Erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles |
2.4 |
2.21 |
|
|
|
|
|
|
|
U/g{Hb} |
|
|
|
0 |
| 49222-3 |
Food allergen panel |
- |
Ser |
Pt |
- |
|
|
ACTIVE |
Food allergen panel - Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.ALLERGY |
|
49222-3 |
|
|
|
|
Order |
|
|
|
0 |
Food allergen Pnl Ser |
|
|
|
N |
|
Allergen; Allergens; ALLERGY TESTING; Alrgen; Food allergen Pnl; Pan; PANEL.ALLERGY; Panl; Pnl; Point in time; Random; Serum; SR; UniversalLabOrders |
2.73 |
2.21 |
|
Panel |
|
|
|
|
|
|
|
|
Release 2.69: DefinitionDescription: Added term description; |
0 |
| 49223-1 |
Colony count |
NCnc |
XXX |
Pt |
Qn |
VC |
|
ACTIVE |
Colony count [#/volume] in Specimen by Visual count |
|
MIN |
DefinitionDescription |
|
|
/mL |
|
|
|
|
|
|
MICRO |
|
49223-1 |
|
VC |
|
|
Both |
|
|
|
0 |
CC # Spec VC |
|
|
|
N |
|
#; ABS; absolute; absolutes; CC; Cnt; Colonies; Count; Count/volume; CT; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Number concentration; Number Concentration (count/vol); Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Visual count |
2.73 |
2.21 |
|
|
|
|
|
|
|
/mL |
|
|
|
0 |
| 49224-9 |
Leukocytes |
Naric |
Semen |
Pt |
Qn |
Microscopy.light.HPF |
|
ACTIVE |
Leukocytes [#/area] in Semen by Microscopy high power field |
|
MIN |
DefinitionDescription |
|
|
/HPF |
|
|
|
|
|
|
HEM/BC |
|
49224-9 |
|
Microscopy.light.HPF |
|
|
Both |
|
|
|
0 |
WBC #/area Smn HPF |
|
|
|
N |
|
#/area; Ejaculate; Genitourinary; GU; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; LM; Micro; Micros; Microscopic; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; URO; Urology; WBC; WBCs; White blood cell; White blood cells |
2.73 |
2.21 |
|
|
|
|
|
|
|
/[HPF] |
|
|
|
0 |
| 49225-6 |
Heptacarboxylate/Creatinine |
SRto |
Urine |
24H |
Qn |
|
|
ACTIVE |
Heptacarboxylate/Creatinine [Molar ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/mol creatinine |
|
|
|
|
|
|
CHEM |
|
49225-6 |
|
|
|
|
Both |
|
|
|
0 |
Heptacarboxylate/Creat 24h Ur-sRto |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Heptacarbox; QNT; Quan; Quant; Quantitative; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.42 |
2.21 |
|
|
|
|
|
|
|
umol/mol{creat} |
|
|
|
0 |
| 49226-4 |
lamiVUDine |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
lamiVUDine [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
49226-4 |
|
|
|
|
Both |
|
|
|
0 |
lamiVUDine SerPl-mCnc |
|
|
|
N |
|
3TC; DRUG/TOXICOLOGY; Drugs; Epivir; Level; LMV; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.4 |
2.21 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 49227-2 |
Stavudine |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Stavudine [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
49227-2 |
|
|
|
|
Both |
|
|
|
0 |
Stavudine SerPl-mCnc |
|
|
|
N |
|
d4T; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Zerit |
2.34 |
2.21 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
